Nautilus Biotechnology, Inc.
NAUT
$0.701
$0.03284.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 147.87M | 138.81M | 129.89M | 140.61M | 167.44M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.85M | 2.79M | 2.93M | 3.60M | 3.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 150.73M | 141.60M | 132.83M | 144.21M | 170.93M |
|
|
|||||
| Total Current Assets | 150.73M | 141.60M | 132.83M | 144.21M | 170.93M |
| Net Property, Plant & Equipment | 29.65M | 30.89M | 32.33M | 33.70M | 35.17M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.18M | 1.18M | 1.18M | 1.18M | 1.18M |
| Total Assets | 213.19M | 227.69M | 242.74M | 259.70M | 272.75M |
|
|
|||||
| Total Accounts Payable | 974.00K | 841.00K | 987.00K | 1.49M | 1.63M |
| Total Accrued Expenses | 2.83M | 2.83M | 2.03M | 2.90M | 2.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.23M | 4.24M | 4.10M | 3.96M | 3.82M |
| Total Finance Division Other Current Liabilities | 112.00K | 245.00K | 518.00K | 314.00K | 304.00K |
| Total Other Current Liabilities | 112.00K | 245.00K | 518.00K | 314.00K | 304.00K |
| Total Current Liabilities | 8.14M | 8.16M | 7.63M | 8.66M | 8.68M |
|
|
|||||
| Total Current Liabilities | 8.14M | 8.16M | 7.63M | 8.66M | 8.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.96M | 25.10M | 26.38M | 27.61M | 28.79M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 32.10M | 33.26M | 34.01M | 36.27M | 37.47M |
|
|
|||||
| Common Stock & APIC | 485.68M | 483.88M | 481.69M | 478.13M | 474.80M |
| Retained Earnings | -304.67M | -289.63M | -273.02M | -255.43M | -238.98M |
| Treasury Stock & Other | 77.00K | 189.00K | 57.00K | 731.00K | -546.00K |
| Total Common Equity | 181.09M | 194.44M | 208.73M | 223.43M | 235.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 181.09M | 194.44M | 208.73M | 223.43M | 235.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 181.09M | 194.44M | 208.73M | 223.43M | 235.28M |
|
|
|||||